Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
14281006 205154 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 205154 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281026 167397 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 167397 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281025 205048 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 205048 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1711 77 12 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
5310983 77 12 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
CHEMBL336208 77 12 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
3352 2329 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5280879 2329 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5863 2329 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
CHEMBL509456 2329 25 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
1756 459 8 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5310954 459 8 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL336292 459 8 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5492386 204750 3 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 204750 3 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
135434015 202217 10 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 202217 10 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
14281041 205245 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91359 205245 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 105638 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 105638 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135409400 203183 72 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
CHEMBL760 203183 72 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
15005606 204821 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 204821 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281012 105516 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL313282 105516 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
14281011 205078 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 205078 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
15005605 204822 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 204822 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005586 106428 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 106428 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 205167 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 205167 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281001 205408 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 205408 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281010 205261 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 205261 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281011 205078 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 205078 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
440317 21533 15 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
CHEMBL131890 21533 15 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
15005591 204770 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88377 204770 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005580 205036 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 205036 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281024 204828 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 204828 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281020 106044 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314093 106044 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 105638 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 105638 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281023 205190 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91044 205190 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005608 205216 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 205216 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281005 205620 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 205620 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005569 110958 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
CHEMBL327580 110958 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
5492386 204750 3 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 204750 3 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281004 205244 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 205244 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
15005588 205409 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 205409 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005581 205178 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90958 205178 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280996 205303 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL91634 205303 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
14280992 204792 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88525 204792 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005576 204778 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 204778 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005584 205042 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 205042 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005574 205283 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 205283 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
5487281 204802 13 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 204802 13 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
14281001 205408 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 205408 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281015 111075 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 111075 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005605 204822 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 204822 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
10016898 205110 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90566 205110 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005600 204747 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88224 204747 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
136677322 3232 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
1739 3232 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
656725 3232 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
CHEMBL1160031 3232 22 None 79 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
14281027 204961 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL89679 204961 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005586 106428 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 106428 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005573 205241 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL91340 205241 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
15005599 204818 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88697 204818 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281000 204957 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
CHEMBL89660 204957 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
15005601 111292 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL328755 111292 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005566 204848 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 204848 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005603 163550 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 163550 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 112128 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 112128 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005571 205232 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91295 205232 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1713 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5957 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
91 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14249 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
DB00171 516 63 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
14281034 110926 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL327374 110926 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005572 163251 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 163251 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
15005566 204848 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 204848 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005564 164861 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 164861 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005578 205292 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 205292 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
5487281 204802 13 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 204802 13 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
15005594 205130 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL90677 205130 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281005 205620 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 205620 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005584 205042 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 205042 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
9999105 204745 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88218 204745 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
135973538 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
1728 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
2966 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
4261196 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
5361 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
CHEMBL265502 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
DB04786 3641 30 None -33 7 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
15005608 205216 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 205216 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281003 205223 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
CHEMBL91259 205223 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
15005603 163550 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 163550 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005598 204824 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88730 204824 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005602 205202 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91127 205202 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135434015 202217 10 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 202217 10 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
15005578 205292 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 205292 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
14281031 205348 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91899 205348 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005606 204821 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 204821 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281026 167397 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 167397 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281016 205248 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 205248 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281018 205423 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL92363 205423 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281036 204819 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
CHEMBL88698 204819 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
15005592 205030 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 205030 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005572 163251 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 163251 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
44323790 204833 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 204833 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281024 204828 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 204828 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005574 205283 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 205283 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005592 205030 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 205030 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005585 205277 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 205277 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 205167 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 205167 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281006 205154 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 205154 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
134687118 192171 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5179763 192171 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5221347 192171 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
14281008 204859 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88955 204859 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005588 205409 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 205409 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 112128 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 112128 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005564 164861 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 164861 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005604 204754 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88265 204754 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005590 204840 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL88835 204840 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
10017729 204727 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 204727 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1712 285 64 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
6022 285 64 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14830 285 64 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
135838395 105659 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
CHEMBL313609 105659 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
14281016 205248 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 205248 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281010 205261 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 205261 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005580 205036 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 205036 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281033 112293 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330677 112293 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281004 205244 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 205244 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
14281025 205048 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 205048 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005576 204778 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 204778 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1755 286 16 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5310996 286 16 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL335206 286 16 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
10017729 204727 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 204727 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281035 204988 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL89876 204988 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005567 205337 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91837 205337 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281015 111075 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 111075 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005585 205277 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 205277 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005577 204722 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 204722 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14280999 204774 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL88395 204774 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
15005570 205294 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
CHEMBL91579 205294 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
14280998 205339 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91843 205339 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005583 205386 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92158 205386 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
44323790 204833 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 204833 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
15005577 204722 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 204722 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
44443919 93967 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL251024 93967 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
23649184 189732 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5176593 189732 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
1776 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5006 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
9854012 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL334966 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
DB06441 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
44443921 168178 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL437204 168178 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
1776 773 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
5006 773 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
9854012 773 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
CHEMBL334966 773 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
DB06441 773 34 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
44555026 111437 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 111437 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11526078 90862 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 90862 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68910943 91655 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 91655 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
44443917 93933 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250832 93933 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
24751997 62484 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 62484 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68550683 190453 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5187308 190453 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
45485968 196060 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 196060 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752128 62459 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 62459 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269461 194510 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 194510 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752129 62466 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 62466 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457371 10249 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
CHEMBL1162189 10249 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
10098947 10227 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162163 10227 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
11786496 10238 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162176 10238 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
53233471 62493 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 62493 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911088 90836 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 90836 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11504760 90846 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 90846 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
53233471 62493 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 62493 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 62480 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 62480 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485965 195087 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 195087 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 195835 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 195835 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 193209 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 193209 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751300 62468 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 62468 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 62480 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 62480 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751575 62483 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 62483 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 62501 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 62501 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650877 199504 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60353 199504 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45272846 193971 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 193971 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801416 10262 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162205 10262 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
45268630 194404 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 194404 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457278 10231 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162167 10231 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
45485930 195508 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 195508 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485858 195636 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 195636 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 195860 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 195860 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751438 62458 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 62458 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15650865 100301 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292978 100301 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650880 100554 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL294588 100554 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650878 199523 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60362 199523 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452737 96430 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL265707 96430 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457411 10255 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162197 10255 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
16739157 10240 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162179 10240 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
44610522 111428 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288125 111428 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11712235 90876 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 90876 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11620159 91656 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 91656 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
68916097 90848 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 90848 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
45485943 195431 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 195431 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485960 195440 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 195440 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 195757 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 195757 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 195763 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 195763 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485900 195830 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 195830 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752269 62457 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 62457 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
131257 201074 3 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62094 201074 3 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452879 160730 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL412171 160730 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45269473 194656 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 194656 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485896 195094 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 195094 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485934 195291 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 195291 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485941 195336 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 195336 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751996 62506 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 62506 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650899 201269 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
CHEMBL63016 201269 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
71740705 90849 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 90849 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45270300 193716 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 193716 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650869 201440 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64144 201440 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650870 201443 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64149 201443 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45270321 193837 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 193837 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
11706300 90843 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 90843 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 90874 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 90874 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45485969 195082 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 195082 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485902 195739 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 195739 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 195868 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 195868 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 195881 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 195881 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752560 62460 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 62460 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485853 195667 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 195667 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269438 194317 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 194317 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24968874 91653 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 91653 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
11273179 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
1770 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
CHEMBL1162175 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
DB05553 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
11273179 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
1770 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
CHEMBL1162175 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
DB05553 3237 4 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
90644282 111425 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 111425 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
16739124 10248 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162188 10248 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485966 195158 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 195158 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 195808 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 195808 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485952 195866 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 195866 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271155 193957 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 193957 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751579 62475 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 62475 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457276 10230 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162166 10230 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
44457392 10252 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
CHEMBL1162194 10252 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
44610468 111430 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 111430 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
54586076 62210 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 62210 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
73345971 90854 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 90854 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
45485937 195561 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 195561 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485859 195774 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 195774 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751581 62174 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 62174 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54586076 62210 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 62210 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45269484 193982 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 193982 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45271145 193250 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 193250 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
69224603 91640 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 91640 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
15983052 91641 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 91641 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
24752130 62462 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 62462 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 62494 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 62494 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
71740819 90850 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 90850 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485857 195791 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 195791 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485938 195839 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 195839 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193170 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193170 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54585885 62486 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 62486 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457274 10229 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162165 10229 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
44554515 111426 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
69224555 91646 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 91646 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68556549 111424 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 111424 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11503160 90868 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 90868 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
24752131 62497 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 62497 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269454 194434 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 194434 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 194989 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 194989 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650861 200994 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61623 200994 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15983175 91645 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 91645 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
45485945 195392 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 195392 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485947 195859 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 195859 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272055 193214 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 193214 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751995 62474 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 62474 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751708 62502 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 62502 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650881 201444 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64153 201444 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453107 154756 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403010 154756 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272035 193409 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 193409 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11570029 90861 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 90861 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
16739091 10236 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162172 10236 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
24752557 62461 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 62461 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485916 195216 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 195216 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
54584960 62510 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 62510 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272842 193941 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 193941 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739125 10237 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162173 10237 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
68916926 139148 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 139148 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
11684912 90856 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 90856 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11561528 90878 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 90878 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68842714 90879 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 90879 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485911 195821 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 195821 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751572 62211 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 62211 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
44453110 154757 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403011 154757 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
15983053 91644 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 91644 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
69224054 91651 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 91651 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
45485961 195320 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 195320 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750723 62469 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 62469 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485954 195867 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 195867 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270322 193104 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 193104 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24750719 62509 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 62509 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24799317 10224 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162160 10224 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
16739092 10235 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162171 10235 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
44457422 10258 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
CHEMBL1162200 10258 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
68918061 90837 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 90837 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11699088 90842 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 90842 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752711 62490 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 62490 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45271154 193987 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 193987 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25022501 94626 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255349 94626 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452925 165860 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL427723 165860 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452982 94667 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255553 94667 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
23649325 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68911289 90866 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 90866 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 90866 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
23649325 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 536 47 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
11993787 91652 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 91652 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
44452926 96954 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL269934 96954 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273798 194005 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 194005 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913927 90873 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 90873 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11532836 90883 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 90883 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68554177 190677 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5190691 190677 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
24751574 62209 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 62209 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751999 62473 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 62473 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485892 195349 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 195349 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 195532 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 195532 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485848 195701 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 195701 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485890 195797 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 195797 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485967 195858 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 195858 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751574 62209 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 62209 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
24751999 62473 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 62473 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650866 199629 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60422 199629 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45273812 194073 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 194073 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44610518 111427 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288124 111427 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
90644279 111436 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
CHEMBL3288133 111436 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
45485963 195406 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 195406 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752561 62487 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 62487 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752421 62496 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 62496 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44452951 97292 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL271643 97292 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485939 195464 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 195464 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 196057 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 196057 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457290 10232 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162168 10232 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485959 195523 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 195523 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
23642329 62476 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 62476 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270323 193567 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 193567 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650882 201247 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62928 201247 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271984 193408 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 193408 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273789 194223 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 194223 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45267750 194243 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 194243 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739158 10228 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162164 10228 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
15983055 91642 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 91642 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
54580044 62511 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 62511 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44453131 154913 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403928 154913 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
11503687 90884 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 90884 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
2746550 62465 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 62465 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485919 195105 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 195105 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485852 195738 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 195738 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485861 195778 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 195778 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485909 195826 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 195826 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270295 193093 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 193093 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579996 62481 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 62481 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 62500 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 62500 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650875 201509 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64383 201509 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742794 201595 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64734 201595 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457324 10239 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162178 10239 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
11561748 91654 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 91654 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
45268594 193880 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 193880 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801573 10253 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162195 10253 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
24752422 62464 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 62464 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11641496 90841 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 90841 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68911008 90872 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 90872 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15983546 91659 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 91659 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
24752271 62488 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 62488 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 10222 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 10222 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45273819 193473 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 193473 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270314 193465 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 193465 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11569565 90875 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 90875 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
1746 2003 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
44457307 2003 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
CHEMBL1162174 2003 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
24752270 62489 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 62489 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485888 195276 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 195276 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44304081 165155 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
CHEMBL424596 165155 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
16739093 10242 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
CHEMBL1162182 10242 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
23649325 536 47 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
7360 536 47 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
CHEMBL2419490 536 47 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
45485862 195792 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 195792 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485905 195834 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 195834 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269465 194570 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 194570 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11677907 90838 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 90838 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
45485956 195879 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 195879 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740352 90880 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 90880 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485894 195767 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 195767 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54580995 62472 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 62472 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983672 91649 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 91649 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
11663657 90857 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 90857 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11656053 90864 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 90864 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68914580 90867 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 90867 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751712 62485 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 62485 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44452947 154636 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402401 154636 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485863 195779 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 195779 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270294 193648 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 193648 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54584163 62212 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 62212 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
11519648 90855 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 90855 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
1765 3745 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
4184 3745 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
9871419 3745 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
CHEMBL398435 3745 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
DB08816 3745 94 None 2 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
45485962 195344 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 195344 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193170 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193170 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 194416 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 194416 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44452898 94627 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255350 94627 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485935 195364 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 195364 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 195880 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 195880 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273782 193826 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 193826 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650862 199734 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60481 199734 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650876 200680 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61062 200680 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742793 201250 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62939 201250 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650873 201694 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL65466 201694 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650872 201846 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66594 201846 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11595497 201448 4 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64162 201448 4 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
16739094 10244 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162184 10244 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485889 195303 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 195303 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268642 193935 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 193935 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650856 100542 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL294535 100542 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650888 201855 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
CHEMBL66647 201855 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
44610519 111429 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 111429 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
24751850 62477 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 62477 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272861 193800 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 193800 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650874 201771 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66027 201771 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650867 101806 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
CHEMBL303366 101806 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
15650864 199624 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60420 199624 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453009 154665 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402592 154665 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485851 195746 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 195746 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272036 193903 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 193903 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650858 198902 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59922 198902 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
24752419 62491 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 62491 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751576 62505 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 62505 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270296 193649 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 193649 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24799834 10250 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162190 10250 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
122192512 123279 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
CHEMBL3623467 123279 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
24751710 62503 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 62503 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583974 62482 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 62482 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457292 10233 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162169 10233 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
11497605 90858 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 90858 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11691323 90865 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 90865 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650857 198735 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
CHEMBL59822 198735 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
44452736 95705 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL260602 95705 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457401 10254 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162196 10254 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
44453109 154704 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402800 154704 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485957 195870 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 195870 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 196058 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 196058 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750874 62498 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 62498 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
45485864 195301 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 195301 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453032 97381 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272113 97381 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
54579997 62504 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 62504 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650871 201623 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64863 201623 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
24752558 90851 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 90851 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45485915 195836 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 195836 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 195827 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 195827 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453132 97562 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272975 97562 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24801414 10225 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162161 10225 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485901 195833 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 195833 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457251 10223 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162159 10223 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
16739123 10245 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162185 10245 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
11627571 90845 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 90845 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485908 195825 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 195825 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740353 90881 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 90881 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485942 195840 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 195840 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650887 201546 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
CHEMBL64555 201546 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
15982393 90877 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 90877 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45272869 193801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 193801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579995 62467 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 62467 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 10222 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 10222 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45485932 195472 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 195472 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267721 195037 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 195037 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44608149 111432 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 111432 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68911155 90871 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 90871 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24799835 10247 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162187 10247 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45272054 193213 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 193213 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
69224988 91650 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 91650 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
68911027 90840 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 90840 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
44452952 154517 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL401780 154517 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24750561 62507 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 62507 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
45267728 194522 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 194522 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650859 101722 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL302875 101722 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68556579 111431 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 111431 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
15650886 100157 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292047 100157 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
44452878 96617 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL267283 96617 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273811 194812 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 194812 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485933 195838 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 195838 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271092 194760 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 194760 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485886 195796 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 195796 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485950 195862 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 195862 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750876 62495 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 62495 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45273818 193169 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 193169 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580993 62455 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 62455 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15983670 91643 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 91643 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
45485903 195831 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 195831 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650860 201148 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62470 201148 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457294 10234 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
CHEMBL1162170 10234 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
45485914 195828 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 195828 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44452921 94806 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL256251 94806 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
2746549 62208 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 62208 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
2746549 62208 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 62208 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485946 196088 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 196088 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
68913220 90839 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 90839 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
45485953 195878 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 195878 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650898 201153 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62500 201153 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11569565 90875 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 90875 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
24751577 62499 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 62499 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485856 195788 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 195788 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650868 198879 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59911 198879 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68911120 91648 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 91648 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
45272902 194032 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 194032 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485898 195490 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 195490 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
73294137 91647 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 91647 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
45485922 195382 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 195382 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267707 194285 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 194285 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 193592 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 193592 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457338 10241 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
CHEMBL1162181 10241 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
25165435 111435 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 111435 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
54581027 62508 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 62508 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269483 193115 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 193115 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272881 193182 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 193182 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 194671 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 194671 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 193630 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 193630 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485921 195333 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 195333 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 195837 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 195837 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273820 193171 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 193171 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913141 90869 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 90869 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
45485918 195289 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 195289 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269472 194655 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 194655 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485849 195743 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 195743 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
90644280 111434 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 111434 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
68911205 91657 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 91657 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
15650883 162710 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL418660 162710 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44241562 194748 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
CHEMBL562982 194748 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
45485936 195368 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 195368 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 195453 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 195453 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829943 194230 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 194230 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268619 193824 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 193824 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15983301 90870 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 90870 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
44457262 10226 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162162 10226 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
24750557 62470 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 62470 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11697626 91658 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 91658 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
24751851 62479 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 62479 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
4742792 198934 9 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL59941 198934 9 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271128 193249 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 193249 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580185 62215 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 62215 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485931 195180 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 195180 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54585098 62214 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 62214 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457247 10221 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 10221 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485855 195787 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 195787 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485917 195812 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 195812 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457247 10221 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 10221 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
11627317 90847 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 90847 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650897 199121 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60083 199121 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11706351 90859 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 90859 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45142449 194646 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 194646 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650863 199336 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60240 199336 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
90644281 111433 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 111433 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
45485958 195437 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 195437 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 195832 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 195832 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485860 195775 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 195775 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268641 193160 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 193160 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752559 62463 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 62463 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751297 62471 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 62471 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 62478 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 62478 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11699570 90860 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 90860 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
54580994 62456 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 62456 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24829780 194781 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 194781 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68910943 91655 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 91655 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11684524 90863 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 90863 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751017 90882 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 90882 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
44452977 95104 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL257651 95104 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272880 193802 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 193802 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44583582 3143 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
5904 3143 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
59448166 3143 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL1207916 3143 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL455536 3143 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
44583582 3143 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
5904 3143 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
59448166 3143 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL1207916 3143 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL455536 3143 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
1765 3745 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 3745 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 3745 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 3745 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 3745 94 None -2 3 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1776 773 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
5006 773 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
9854012 773 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
CHEMBL334966 773 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
DB06441 773 34 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
10340 1097 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
137553172 1097 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
1764 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
189762 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
CHEMBL606240 76 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
1732 446 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
25243905 446 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
16741348 744 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
1766 744 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
139031067 1089 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
6148 1089 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
73755176 1089 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
3384 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
3384 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
5311009 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
5311009 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
CHEMBL1160359 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
CHEMBL1160359 470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
1776 773 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
5006 773 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
9854012 773 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
CHEMBL334966 773 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
DB06441 773 34 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
121990 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1710 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1763 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
CHEMBL435402 75 12 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1755 286 16 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
5310996 286 16 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
CHEMBL335206 286 16 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
1776 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
5006 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
9854012 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
CHEMBL334966 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
DB06441 773 34 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
10405534 3205 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1771 3205 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
CHEMBL3526431 3205 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1769 2004 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
91827342 2004 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
16681707 746 4 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
1767 746 4 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
CHEMBL2172275 746 4 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
11273179 3237 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1770 3237 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
CHEMBL1162175 3237 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
DB05553 3237 4 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1765 3745 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
4184 3745 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
9871419 3745 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
CHEMBL398435 3745 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
DB08816 3745 94 None 2 3 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
1776 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5006 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
9854012 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL334966 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
DB06441 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
1776 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
5006 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
9854012 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
CHEMBL334966 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
DB06441 773 34 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
10557443 10114 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
CHEMBL1160364 10114 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
66575818 113557 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 113557 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 111426 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
49764561 189533 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5173489 189533 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
49764180 189933 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5179719 189933 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
46931928 190231 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5184268 190231 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763085 190829 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5192953 190829 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
49764183 190985 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5195237 190985 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763087 191507 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5203416 191507 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
15983053 91644 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 91644 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
66854978 190678 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5190693 190678 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
87180479 191752 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207212 191752 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
1765 3745 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
4184 3745 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
9871419 3745 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
CHEMBL398435 3745 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
DB08816 3745 94 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
118711090 113339 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 113339 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67460312 113109 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322621 113109 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711072 113321 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 113321 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711074 113323 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 113323 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711077 113326 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 113326 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711079 113328 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 113328 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711087 113336 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 113336 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711091 113340 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 113340 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576450 113383 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 113383 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54581027 62508 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 62508 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580044 62511 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 62511 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600063 126128 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
CHEMBL3652613 126128 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
118711172 113381 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 113381 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127039360 136604 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
127040666 136604 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745863 136604 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747870 136604 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
25165435 111435 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 111435 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
44608149 111432 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 111432 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711093 113342 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 113342 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 536 47 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 536 47 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 536 47 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24968874 91653 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 91653 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
118711190 113405 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113405 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 113406 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113406 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113407 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113407 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
67460624 113121 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322632 113121 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607689 103722 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 103722 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983055 91642 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 91642 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
24751997 62484 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 62484 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL54256 193269 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 664 7 2 14 1.5 CS(=O)(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(S(C)(=O)=O)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711084 113333 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 113333 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711086 113335 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 113335 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711088 113337 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 113337 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 113386 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 113386 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 113393 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113393 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
11684524 90863 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 90863 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11561528 90878 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 90878 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752129 62466 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 62466 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751577 62499 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 62499 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968628 164567 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227647 164567 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145971167 164589 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4227969 164589 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
145967502 164626 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228684 164626 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
44610519 111429 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 111429 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68556579 111431 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 111431 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711089 113338 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 113338 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127038951 136613 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240906 136613 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746312 136613 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747879 136613 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
71607634 103715 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 103715 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711083 113332 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 113332 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
90644280 111434 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 111434 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
118711091 113340 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 113340 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 113397 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 113397 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
68600322 126126 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652611 126126 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
15983175 91645 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 91645 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
118711180 113390 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 113390 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576220 113408 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11684912 90856 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 90856 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706351 90859 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 90859 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911120 91648 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 91648 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
118711179 113389 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 113389 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983175 91645 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 91645 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
24751575 62483 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 62483 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
22185065 164515 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226930 164515 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71740352 90880 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 90880 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711096 113345 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 113345 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
67463039 113102 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322614 113102 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711074 113323 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 113323 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607553 103716 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 103716 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44554515 111426 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
2741913 113551 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 113551 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
67460741 113119 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322630 113119 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
16681707 746 4 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 746 4 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 746 4 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
66575821 113430 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 113430 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
24752558 90851 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 90851 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
118711969 113552 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 113552 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
25175044 126118 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
CHEMBL3652603 126118 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
24985991 191170 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
CHEMBL5197988 191170 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
127041005 136609 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240702 136609 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746901 136609 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747875 136609 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
118711185 113398 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 113398 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
71607634 103715 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 103715 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711077 113326 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 113326 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 536 47 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
127040347 136602 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241743 136602 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747704 136602 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747869 136602 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
11504760 90846 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 90846 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11712235 90876 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 90876 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
44610468 111430 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 111430 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711090 113339 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 113339 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711092 113341 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 113341 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
46241019 136598 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745979 136598 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747865 136598 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751999 62473 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 62473 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751999 62473 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 62473 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751995 62474 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 62474 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968144 164535 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227196 164535 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 113400 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 113400 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
12000767 113095 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322597 113095 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711193 113410 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 113410 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
71264539 103723 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098249 103723 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983672 91649 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 91649 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
118711177 113387 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 113387 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 113404 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113404 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118710245 113139 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 113139 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
74220534 113431 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 113431 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
11532836 90883 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 90883 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987950 164648 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228996 164648 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711071 113320 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 113320 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711249 113436 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 113436 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
145970219 164562 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227595 164562 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145969360 164632 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228736 164632 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
118711064 113314 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113314 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607662 103713 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098236 103713 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44762396 113550 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 113550 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
59534140 113131 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322642 113131 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11706351 90859 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 90859 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
71607589 103711 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 103711 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11993787 91652 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 91652 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
24751708 62502 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 62502 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711064 113314 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113314 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463112 113099 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322611 113099 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
71607592 103714 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 103714 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
71607664 103719 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098243 103719 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
44762396 113550 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 113550 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
67460401 113103 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322615 113103 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68600802 126121 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652606 126121 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
15983546 91659 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 91659 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
66575899 113429 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 113429 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
118711970 113553 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326903 113553 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
66575899 113429 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
CHEMBL3325891 113429 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
44296486 188344 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL50806 188344 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL540200 193190 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
11684912 90856 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 90856 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
23642329 62476 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 62476 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711075 113324 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 113324 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711098 113348 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 113348 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 113397 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 113397 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
24752560 62460 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 62460 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 62478 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 62478 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 62501 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 62501 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145967823 164394 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4225138 164394 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
71607553 103716 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 103716 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67462688 113101 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322613 113101 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12002005 113112 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322624 113112 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
1776 773 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
5006 773 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
9854012 773 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
CHEMBL334966 773 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
DB06441 773 34 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
11561528 90878 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 90878 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL300240 101334 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 652 9 2 14 3.0 CCOC(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C(=O)OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711076 113325 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 113325 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66575818 113557 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 113557 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
69224555 91646 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 91646 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
24751572 62211 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 62211 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
24752269 62457 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 62457 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752559 62463 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 62463 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
10292521 164412 7 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225415 164412 7 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
22184925 164581 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
CHEMBL4227910 164581 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
6918456 14333 107 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
CHEMBL1201772 14333 107 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
118711973 113556 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 113556 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145970653 164530 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227170 164530 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607633 103712 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098235 103712 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11569565 90875 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 90875 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711174 113384 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 113384 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 113385 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 113385 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11503160 90868 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 90868 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11503687 90884 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 90884 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913927 90873 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 90873 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24750723 62469 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 62469 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750557 62470 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 62470 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145967657 164500 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226648 164500 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
24752128 62459 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 62459 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750719 62509 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 62509 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145970872 164505 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226722 164505 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
15983670 91643 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 91643 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
118711073 113322 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 113322 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607666 103721 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 103721 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67459391 113104 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322616 113104 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24786234 139204 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 139204 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1776 773 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
5006 773 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
9854012 773 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
CHEMBL334966 773 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
DB06441 773 34 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
24786234 139204 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 139204 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1756 459 8 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5310954 459 8 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL336292 459 8 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
87416471 191063 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5196387 191063 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
73603967 113432 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 113432 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
15982393 90877 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 90877 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576297 113347 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 113347 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711190 113405 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113405 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113407 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113407 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113408 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11620159 91656 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 91656 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
11697626 91658 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 91658 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
145970444 164585 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227949 164585 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711185 113398 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 113398 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
90644282 111425 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 111425 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711972 113555 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 113555 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67462328 113107 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322619 113107 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461716 113116 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322628 113116 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001755 113130 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322641 113130 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68913927 90873 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 90873 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
127039361 136605 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
127039919 136605 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746192 136605 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747871 136605 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11699088 90842 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 90842 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752130 62462 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 62462 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145969883 164379 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4224920 164379 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
54697995 193047 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL53491 193047 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
145986354 164673 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229217 164673 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
12002012 113135 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322646 113135 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67464394 113111 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322623 113111 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
23649325 536 47 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
66576377 113391 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113391 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
71607631 103717 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 103717 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
127039316 136601 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46196450 136601 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747385 136601 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747868 136601 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
69223141 91639 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419480 91639 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
118711067 113318 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113318 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
44296002 14603 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206713 14603 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299307 14603 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
168274164 189805 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5177774 189805 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL301991 101573 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 536 5 2 10 3.3 Cc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
145969318 164573 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227756 164573 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
67463698 113125 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322636 113125 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 111426 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118710244 113138 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322649 113138 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11570029 90861 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 90861 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
73294137 91647 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 91647 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
118711183 113396 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 113396 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
24751438 62458 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 62458 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751300 62468 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 62468 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11451 3150 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
132574707 3150 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
CHEMBL4116316 3150 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
118711972 113555 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 113555 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911027 90840 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 90840 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
24751850 62477 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 62477 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983546 91659 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 91659 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
127040000 136599 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241331 136599 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746558 136599 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747866 136599 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
73345971 90854 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 90854 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
24751017 90882 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 90882 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751581 62174 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 62174 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54580185 62215 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 62215 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
60606 61216 68 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
CHEMBL1771 61216 68 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
137630000 160471 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4087247 160471 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116405 160471 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
67460268 113132 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322643 113132 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627571 90845 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 90845 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145970953 164614 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228415 164614 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711972 113555 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 113555 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67461519 113106 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322618 113106 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 90871 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 90871 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576450 113383 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 113383 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11526078 90862 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 90862 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987961 164677 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229257 164677 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711249 113436 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 113436 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
12000848 113096 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322598 113096 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 90871 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 90871 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576298 113308 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113308 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711102 113353 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 113353 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459575 113110 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322622 113110 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
145971125 164514 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226913 164514 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 113400 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 113400 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
24968874 91653 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 91653 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
54580993 62455 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 62455 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580995 62472 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 62472 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 62500 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 62500 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711065 113315 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
CHEMBL3325626 113315 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
66575821 113430 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 113430 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
67464143 113105 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322617 113105 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461890 113124 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322635 113124 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68598655 126124 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652609 126124 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711173 113382 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 113382 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607589 103711 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 103711 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983053 91644 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 91644 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
68556549 111424 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 111424 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711098 113348 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 113348 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
16681707 746 4 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 746 4 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 746 4 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
71607631 103717 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 103717 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
15983672 91649 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 91649 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
69224054 91651 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 91651 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
68913220 90839 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 90839 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
118710243 113134 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322645 113134 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
137630586 160528 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4081274 160528 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116838 160528 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
25022583 126131 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
CHEMBL3652616 126131 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
25022583 126131 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
CHEMBL3652616 126131 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
59534139 113141 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322652 113141 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44464779 113142 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 113142 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
42629406 190566 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5188874 190566 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
69224988 91650 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 91650 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
25110832 189360 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5170672 189360 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
66576297 113347 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 113347 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576451 113392 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113392 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 113406 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113406 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113408 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 120049 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120049 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120049 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 113404 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113404 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711190 113405 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 113405 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 113407 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 113407 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113408 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11503687 90884 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 90884 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711974 113558 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326908 113558 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 90836 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 90836 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11677907 90838 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 90838 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
118711067 113318 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113318 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 120050 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120050 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120050 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001296 113120 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322631 113120 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
46241233 136600 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746620 136600 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747867 136600 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
2746550 62465 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 62465 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
127040676 136606 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240598 136606 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746188 136606 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747872 136606 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751297 62471 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 62471 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
22916 14541 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL1206272 14541 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL256057 14541 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
71607687 103725 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098251 103725 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983670 91643 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 91643 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
11547134 191919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
CHEMBL5209548 191919 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
2746549 62208 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 62208 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 62494 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 62494 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 3745 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
4184 3745 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
9871419 3745 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
CHEMBL398435 3745 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
DB08816 3745 94 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
23649325 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
23649325 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 536 47 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24751579 62475 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 62475 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15982393 90877 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 90877 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711094 113343 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 113343 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607689 103722 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 103722 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
2746549 62208 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 62208 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24752131 62497 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 62497 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 113433 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 113433 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 113409 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 113409 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 113395 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113395 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
168293684 191584 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5204363 191584 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
127040999 136608 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240799 136608 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746598 136608 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747874 136608 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
12001662 113137 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322648 113137 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607632 103718 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 103718 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
118711066 113317 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113317 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54732977 101294 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL299983 101294 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
54732982 101403 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL300750 101403 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
137630492 160518 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4090874 160518 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4116755 160518 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
67460935 113115 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322627 113115 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11691323 90865 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 90865 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711186 113399 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 113399 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
54732979 187812 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL50192 187812 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
66919972 189479 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5172707 189479 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
11519648 90855 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 90855 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24751712 62485 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 62485 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68916097 90848 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 90848 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
68911205 91657 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 91657 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
68911205 91657 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 91657 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
66576448 120049 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120049 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120049 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
118710245 113139 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 113139 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68597944 126129 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652614 126129 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68601276 126134 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652619 126134 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
44554515 111426 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
44464779 113142 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 113142 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11569565 90875 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 90875 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL540200 193190 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Compound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyteCompound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyte
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
74220534 113431 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 113431 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
67462098 113136 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322647 113136 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66576298 113308 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113308 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711083 113332 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 113332 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711093 113342 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 113342 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711097 113346 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 113346 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711101 113351 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 113351 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711102 113353 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 113353 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711172 113381 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 113381 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711174 113384 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 113384 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711180 113390 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 113390 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 113393 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113393 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576610 113394 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113394 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
66576296 113404 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 113404 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113408 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576221 113434 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 113434 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
66575819 113316 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113316 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 113391 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113391 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
118711191 113406 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 113406 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711073 113322 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 113322 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711973 113556 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 113556 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 111426 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711097 113346 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 113346 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607665 103724 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 103724 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711066 113317 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113317 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54584163 62212 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 62212 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
1765 3745 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
4184 3745 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
9871419 3745 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
CHEMBL398435 3745 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
DB08816 3745 94 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
11569565 90875 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 90875 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
68916097 90848 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 90848 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
12001028 113017 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3321766 113017 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118710246 113140 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322651 113140 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11663657 90857 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 90857 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68914580 90867 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 90867 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24750876 62495 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 62495 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145970029 164611 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4228398 164611 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
23649325 536 47 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118711099 113349 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 113349 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983301 90870 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 90870 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68916926 139148 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 139148 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
2741913 113551 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 113551 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
145967859 164449 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4225935 164449 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
118711086 113335 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 113335 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 113352 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 113352 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118710241 113108 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322620 113108 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67459247 113129 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322640 113129 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66575819 113316 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113316 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
54579997 62504 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 62504 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711078 113327 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 113327 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711971 113554 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
CHEMBL3326904 113554 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
53233471 62493 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 62493 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
53233471 62493 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 62493 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
66576451 113392 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113392 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711181 113393 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 113393 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576221 113434 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 113434 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
71607632 103718 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 103718 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11561748 91654 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 91654 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
44296000 14607 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206719 14607 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299895 14607 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
24752421 62496 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 62496 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 113433 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 113433 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
168283736 192291 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5183695 192291 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5222086 192291 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
68911008 90872 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 90872 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
71607665 103724 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 103724 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
24752557 62461 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 62461 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598694 126127 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652612 126127 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
68599106 126130 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652615 126130 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68599934 126132 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
CHEMBL3652617 126132 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
1765 3745 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
4184 3745 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
9871419 3745 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
CHEMBL398435 3745 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
DB08816 3745 94 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
66575819 113316 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 113316 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
127047545 139033 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 139033 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
66576610 113394 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113394 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
16066663 77774 32 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
CHEMBL2103828 77774 32 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
118711085 113334 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 113334 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711089 113338 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 113338 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 113385 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 113385 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711177 113387 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 113387 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711178 113388 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 113388 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 113391 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 113391 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
66576375 120050 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120050 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120050 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576298 113308 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 113308 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576451 113392 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 113392 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 113395 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113395 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 113408 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 120049 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 120049 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 120049 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 120050 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 120050 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 120050 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
1765 3745 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
4184 3745 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
9871419 3745 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
CHEMBL398435 3745 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
DB08816 3745 94 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
11561748 91654 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 91654 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
24752271 62488 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 62488 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752270 62489 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 62489 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 3745 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
4184 3745 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
9871419 3745 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
CHEMBL398435 3745 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
DB08816 3745 94 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
67460979 113114 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322626 113114 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67463220 113128 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322639 113128 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11656053 90864 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 90864 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184858 164436 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4225733 164436 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
12001567 113117 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322629 113117 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001030 113123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322634 113123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711188 113401 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325799 113401 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
54583974 62482 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 62482 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711250 113437 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 113437 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
67462183 113126 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322637 113126 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627317 90847 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 90847 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54584960 62510 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 62510 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54585885 62486 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 62486 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711194 113411 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 113411 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
24752561 62487 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 62487 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68910943 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
67462816 113113 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322625 113113 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24750874 62498 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 62498 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
118711189 113403 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325800 113403 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
69224555 91646 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 91646 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68911289 90866 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL2402255 90866 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL5206028 90866 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
68911289 90866 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 90866 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 90866 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
66575899 113429 2 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 113429 2 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
68910943 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
137630841 160554 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4069492 160554 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4117118 160554 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
118711081 113330 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 113330 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711182 113395 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 113395 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 113409 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 113409 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
24751998 62480 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 62480 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751851 62479 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 62479 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751998 62480 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 62480 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711070 113319 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 113319 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711075 113324 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 113324 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11949423 191767 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207480 191767 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
24750561 62507 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 62507 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
11503160 90868 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 90868 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68918061 90837 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 90837 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
71607663 103720 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098244 103720 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11677907 90838 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 90838 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
46233355 198855 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL598998 198855 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 111426 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 111426 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
68601482 126120 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
CHEMBL3652605 126120 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
118711087 113336 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 113336 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607592 103714 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 103714 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11641496 90841 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 90841 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711095 113344 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 113344 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 113386 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 113386 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71740819 90850 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 90850 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579996 62481 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 62481 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600085 126119 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
CHEMBL3652604 126119 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
15983052 91641 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 91641 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
68910943 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 91655 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11699570 90860 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 90860 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68842714 90879 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 90879 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579995 62467 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 62467 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11497605 90858 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 90858 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
10294407 164545 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227347 164545 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
69224054 91651 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 91651 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
66576220 113408 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
73603967 113432 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 113432 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
118711973 113556 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 113556 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711179 113389 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 113389 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711094 113343 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 113343 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711100 113350 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 113350 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 113352 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 113352 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711193 113410 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 113410 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576610 113394 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 113394 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
44555026 111437 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 111437 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68600647 126123 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652608 126123 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711079 113328 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 113328 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 113331 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 113331 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24937181 195763 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL569732 195763 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
118711088 113337 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 113337 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001479 113122 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322633 113122 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
127038949 136612 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46241636 136612 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746852 136612 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747878 136612 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11620159 91656 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 91656 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
118711248 113435 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 113435 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
24752419 62491 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 62491 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711100 113350 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 113350 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711183 113396 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 113396 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
118710242 113133 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322644 113133 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24752422 62464 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 62464 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44296487 101551 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
CHEMBL301805 101551 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
24751576 62505 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 62505 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11519648 90855 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 90855 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
15983301 90870 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 90870 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
145969559 164591 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228020 164591 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
68599474 126133 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652618 126133 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
66576220 113408 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 113408 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
127047545 139033 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 139033 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
118711969 113552 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 113552 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL53599 193062 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 568 7 2 12 2.7 COc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711070 113319 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 113319 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711078 113327 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 113327 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 113331 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 113331 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711099 113349 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 113349 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711173 113382 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 113382 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711067 113318 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 113318 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
11699570 90860 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 90860 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
90644281 111433 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 111433 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
118711194 113411 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 113411 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
118711101 113351 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 113351 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24752711 62490 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 62490 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598525 126122 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652607 126122 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711064 113314 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 113314 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711080 113329 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 113329 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
22184814 164409 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225388 164409 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607666 103721 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 103721 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
68913141 90869 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 90869 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711178 113388 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 113388 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145967492 164616 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228420 164616 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145986356 164674 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229219 164674 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
145970199 164526 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227070 164526 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711085 113334 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 113334 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11684524 90863 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 90863 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 90874 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 90874 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711076 113325 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 113325 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 62210 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 62210 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
69224603 91640 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 91640 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
118711092 113341 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 113341 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 62210 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 62210 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184796 164609 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4228342 164609 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
23649325 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68598844 126125 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
CHEMBL3652610 126125 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
23649325 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 536 47 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118710247 113143 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322654 113143 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911289 90866 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 90866 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 90866 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11526078 90862 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 90862 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711080 113329 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 113329 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711095 113344 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 113344 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711096 113345 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 113345 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
69224988 91650 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 91650 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
22185105 164574 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4227774 164574 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
118711072 113321 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 113321 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24751574 62209 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 62209 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751574 62209 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 62209 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
118711066 113317 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 113317 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711250 113437 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 113437 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
127040997 136607 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240803 136607 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746502 136607 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747873 136607 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
71740705 90849 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 90849 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913141 90869 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 90869 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711071 113320 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 113320 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711084 113333 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 113333 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 90836 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 90836 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706300 90843 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 90843 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711081 113330 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 113330 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459556 113100 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322612 113100 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751996 62506 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 62506 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711248 113435 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 113435 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
54580994 62456 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 62456 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
12000684 113127 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322638 113127 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751710 62503 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 62503 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
66575818 113557 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 113557 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463976 113097 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322599 113097 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
54585098 62214 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 62214 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711186 113399 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 113399 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
71740353 90881 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 90881 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
1756 459 8 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
5310954 459 8 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
CHEMBL336292 459 8 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
168296904 192378 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5199350 192378 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5222620 192378 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
20690446 93970 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL251041 93970 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
58334279 190060 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5181634 190060 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
45485957 195870 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 195870 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485932 195472 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 195472 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485963 195406 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 195406 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232890 199237 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601696 199237 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485958 195437 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 195437 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485931 195180 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 195180 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44443939 93759 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249790 93759 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
46232949 199207 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601489 199207 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485966 195158 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 195158 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485957 195870 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL570295 195870 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485898 195490 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 195490 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485962 195344 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 195344 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485943 195431 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 195431 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485959 195523 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 195523 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232887 199236 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601695 199236 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44129060 81899 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172149 81899 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485961 195320 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 195320 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485965 195087 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 195087 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485968 196060 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 196060 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232894 199239 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601698 199239 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485952 195866 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 195866 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485886 195796 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 195796 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141136 195674 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL569097 195674 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 199233 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601692 199233 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 199233 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601692 199233 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232896 199269 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601903 199269 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485889 195303 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 195303 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485922 195382 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 195382 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 195532 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 195532 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485849 195743 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 195743 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485850 195745 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569680 195745 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 195832 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 195832 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232899 199271 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601905 199271 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485917 195812 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 195812 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 195868 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 195868 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139405 197683 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590950 197683 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139408 199084 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600575 199084 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485938 195839 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 195839 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233241 196854 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578094 196854 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233234 197795 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591712 197795 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232943 199203 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601485 199203 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485915 195836 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 195836 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 195880 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 195880 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44129137 81880 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172129 81880 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233325 196902 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578522 196902 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 197483 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589519 197483 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140552 197942 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592850 197942 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141342 199200 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601478 199200 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 197483 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589519 197483 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232879 197515 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589804 197515 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141342 199200 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601478 199200 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
20690429 96578 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL266922 96578 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485969 195082 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 195082 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485914 195828 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 195828 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140751 197666 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590749 197666 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233243 197871 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592410 197871 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140554 197873 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592441 197873 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232911 197551 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590008 197551 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232950 197572 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590146 197572 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232942 197587 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590260 197587 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232940 199201 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601483 199201 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140553 197948 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592883 197948 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233242 196898 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578507 196898 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 197456 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589335 197456 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 197456 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589335 197456 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
1765 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
4184 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
9871419 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
CHEMBL398435 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
DB08816 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
44443935 153329 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398295 153329 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485944 195112 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565573 195112 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 195268 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 195268 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272861 193800 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 193800 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270323 193567 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551020 193567 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141135 196852 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578076 196852 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139404 197906 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592650 197906 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139592 198724 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598161 198724 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142222 199059 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600370 199059 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141980 199436 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603145 199436 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232921 197581 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590254 197581 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232930 199168 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601274 199168 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485950 195862 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 195862 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
21130371 14703 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1207842 14703 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL445413 14703 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
106250 14732 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
106250 14732 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208092 14732 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208092 14732 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496030 14732 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496030 14732 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25125169 14733 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208096 14733 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496229 14733 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123834 14761 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208284 14761 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522725 14761 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
3018777 59919 5 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1671995 59919 5 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1741070 59919 5 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
44129368 81935 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172270 81935 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129451 81890 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172139 81890 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485887 195241 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566309 195241 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 195453 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 195453 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485930 195508 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 195508 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 195757 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 195757 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 195763 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 195763 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485856 195788 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 195788 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271154 193987 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 193987 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45269438 194317 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 194317 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271154 193987 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556522 193987 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269438 194317 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560009 194317 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233330 196798 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577630 196798 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142218 197507 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589719 197507 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139770 197509 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589737 197509 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140934 197821 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591991 197821 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233240 197870 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592409 197870 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139585 197890 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592535 197890 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139767 197946 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592881 197946 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139951 198521 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596750 198521 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140164 199442 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603151 199442 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232882 197544 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590001 197544 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232927 199166 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601272 199166 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855175 81889 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172138 81889 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45140745 198938 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599422 198938 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
24829943 194230 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 194230 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24829943 194230 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559259 194230 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45267707 194285 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 194285 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233356 198856 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598999 198856 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485848 195701 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 195701 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485863 195779 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 195779 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 195827 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 195827 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485946 196088 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 196088 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 193209 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 193209 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267751 193209 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540672 193209 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141347 196855 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578102 196855 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139407 197439 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589216 197439 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140754 197680 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590874 197680 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141343 198755 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598387 198755 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232920 199193 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601447 199193 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232884 199234 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601693 199234 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232895 199240 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601699 199240 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142448 199987 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL606209 199987 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
11950159 195429 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 195429 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16120270 14760 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208282 14760 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522053 14760 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485864 195301 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 195301 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
3711684 14763 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208290 14763 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524284 14763 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45139955 199437 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603146 199437 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232904 197497 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589597 197497 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232933 197585 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590258 197585 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487796 195270 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566447 195270 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
66854575 81895 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172145 81895 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
46233389 198756 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL598388 198756 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233222 198610 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597380 198610 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44126037 1088 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
5905 1088 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
CHEMBL2172277 1088 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
45485907 195819 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570020 195819 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273819 193473 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 193473 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268593 194927 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564150 194927 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
1765 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
4184 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
9871419 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
CHEMBL398435 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
DB08816 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
45273819 193473 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL550278 193473 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268593 194927 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564150 194927 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140361 197783 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591619 197783 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487821 195432 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 195432 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45267728 194522 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561484 194522 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233388 197487 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL589528 197487 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233630 198860 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599006 198860 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273798 194005 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 194005 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270318 193488 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550415 193488 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485861 195778 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 195778 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193170 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193170 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 193630 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 193630 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268642 193935 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 193935 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 193170 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 193170 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 193171 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539734 193171 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141581 197518 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589817 197518 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140155 198930 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
CHEMBL599399 198930 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
24829442 199558 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603866 199558 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631970 193170 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539733 193170 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45273820 193171 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539734 193171 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232902 197453 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589298 197453 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45270274 194075 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
CHEMBL557553 194075 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
13991590 156812 44 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL4077922 156812 44 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45269482 193114 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538644 193114 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 194671 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 194671 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 194671 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562485 194671 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485858 195636 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 195636 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232923 197554 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590039 197554 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232916 199303 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602110 199303 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487809 195267 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 195267 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45271977 193342 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549307 193342 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233386 198897 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599202 198897 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487841 195118 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 195118 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45485882 195794 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569912 195794 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141770 197659 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590742 197659 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232931 197559 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590087 197559 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25863 59931 53 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1672104 59931 53 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1741102 59931 53 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
11950328 195592 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 195592 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856100 81886 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
CHEMBL2172135 81886 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
71455298 81915 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172166 81915 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11950328 195592 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 195592 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272880 193802 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 193802 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272036 193903 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 193903 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271155 193957 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 193957 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272880 193802 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552973 193802 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272036 193903 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL555342 193903 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271155 193957 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556330 193957 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140162 197782 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591593 197782 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139945 198516 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL596732 198516 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
45139953 199327 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL602294 199327 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232922 197582 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590255 197582 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66854919 81881 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172130 81881 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487838 195623 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 195623 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
66854714 81888 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
CHEMBL2172137 81888 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
45485854 195790 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569908 195790 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123180 14650 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207384 14650 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL401859 14650 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46233668 198551 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL596962 198551 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
45272035 193409 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 193409 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485893 195071 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565249 195071 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485857 195791 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 195791 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11670815 195514 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 195514 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
66856844 81906 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172156 81906 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141776 197952 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592887 197952 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
9953334 93937 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250848 93937 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45271128 193249 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 193249 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25125168 14734 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25125168 14734 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208098 14734 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208098 14734 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496401 14734 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496401 14734 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45487813 195397 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 195397 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44128982 81892 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172142 81892 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45140353 198646 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
CHEMBL597563 198646 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
87791 14741 9 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL1208117 14741 9 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL498229 14741 9 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
45485900 195830 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 195830 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 195860 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 195860 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485953 195878 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 195878 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140551 197940 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592825 197940 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232951 197532 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589901 197532 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232945 199204 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601486 199204 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485936 195368 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 195368 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 195835 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 195835 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141579 197571 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590140 197571 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140938 197706 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591048 197706 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140748 197949 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592884 197949 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631974 199272 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 199272 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485859 195774 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 195774 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 195837 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 195837 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485911 195821 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 195821 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233229 196748 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577236 196748 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140932 197911 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592678 197911 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233329 196974 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579330 196974 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141981 197491 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589554 197491 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139771 199438 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603147 199438 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140928 199638 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604288 199638 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485888 195276 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 195276 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485956 195879 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 195879 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141986 196651 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL576331 196651 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141134 196828 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577844 196828 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139769 197897 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592577 197897 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232944 197577 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590194 197577 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9823796 153491 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398434 153491 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485908 195825 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 195825 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142445 197661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590744 197661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139772 197663 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590746 197663 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142223 199082 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600573 199082 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140365 199441 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603150 199441 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232893 197547 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590004 197547 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232941 199202 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601484 199202 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485896 195094 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 195094 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485933 195838 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 195838 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233233 196853 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578080 196853 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141128 197617 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590418 197617 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485935 195364 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 195364 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485855 195787 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 195787 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233327 196939 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578899 196939 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140558 197691 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590990 197691 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140165 199443 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603152 199443 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232883 197521 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589824 197521 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 199273 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 199273 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232917 199304 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602111 199304 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485918 195289 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 195289 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 195808 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 195808 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855197 81938 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172273 81938 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45269472 194655 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562405 194655 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141582 196887 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578335 196887 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140160 198859 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599005 198859 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66856952 81885 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172134 81885 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487850 195311 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 195311 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45272846 193971 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 193971 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66856999 81887 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172136 81887 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272902 194032 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 194032 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24830601 198960 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599605 198960 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44610760 195624 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 195624 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45269472 194655 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 194655 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25128138 14748 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208159 14748 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL502519 14748 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46232936 199170 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601276 199170 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
39073052 195296 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566661 195296 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
67204 14759 13 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208280 14759 13 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL521709 14759 13 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
45487790 197294 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 197294 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270294 193648 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 193648 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129522 81910 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172160 81910 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485881 195793 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569911 195793 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485901 195833 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 195833 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855285 81914 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172165 81914 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141772 197436 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589198 197436 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141982 197662 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590745 197662 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140936 197730 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591226 197730 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232915 197536 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589930 197536 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232925 197583 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590256 197583 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487789 195471 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 195471 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16066663 77774 32 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
CHEMBL2103828 77774 32 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
45269461 194510 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 194510 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16066663 77774 32 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
CHEMBL2103828 77774 32 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
44128901 81878 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172127 81878 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129058 81883 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172132 81883 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487789 195471 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 195471 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66854417 81908 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172158 81908 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
6689 14730 14 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208089 14730 14 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL495834 14730 14 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
45273818 193169 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 193169 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70683418 73608 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021587 73608 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44583582 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
5904 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
59448166 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL1207916 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL455536 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
45487837 197321 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 197321 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
11955421 197353 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 197353 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
66919940 81941 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172279 81941 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271978 193343 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549308 193343 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271978 193343 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549308 193343 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
167524 14483 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1205665 14483 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL131271 14483 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
66919996 81943 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172280 81943 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44583582 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
5904 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
59448166 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL1207916 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL455536 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
20299057 59927 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1672103 59927 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1741093 59927 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
46233230 197810 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591874 197810 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232886 199235 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601694 199235 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25114519 14762 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208288 14762 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524064 14762 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268619 193824 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 193824 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70687668 73607 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021586 73607 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232932 199169 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601275 199169 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485853 195667 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 195667 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270323 193567 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 193567 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271092 194760 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 194760 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487817 195591 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 195591 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
44129524 81939 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172274 81939 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271092 194760 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563041 194760 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269465 194570 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 194570 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66919958 81945 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172282 81945 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233130 198830 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598821 198830 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268594 193880 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 193880 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233324 197947 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL592882 197947 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45139949 198752 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
CHEMBL598376 198752 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
45139765 198828 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598816 198828 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128387 81929 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172264 81929 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233096 199922 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605847 199922 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485903 195831 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 195831 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271984 193408 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 193408 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
10202847 197336 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585852 197336 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45271984 193408 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549724 193408 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232903 197549 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590006 197549 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487843 195507 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 195507 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487817 195591 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 195591 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
10109037 195428 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567695 195428 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45485934 195291 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 195291 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 196058 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 196058 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 195268 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 195268 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233228 196829 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577854 196829 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139768 197937 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592810 197937 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485967 195858 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 195858 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855732 81898 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172148 81898 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44443933 97821 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL274713 97821 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
46233237 196971 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579289 196971 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 197495 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589584 197495 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140366 199032 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600055 199032 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 197495 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589584 197495 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142219 197578 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590208 197578 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140930 197604 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590364 197604 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140937 197731 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591227 197731 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232947 199205 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601487 199205 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485954 195867 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 195867 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 193170 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
CHEMBL539733 193170 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
45272869 193801 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552972 193801 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140931 197658 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590741 197658 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232935 197556 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590069 197556 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485960 195440 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 195440 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 195881 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 195881 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233328 196953 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579081 196953 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140557 197674 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590798 197674 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485902 195739 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 195739 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140939 197723 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591185 197723 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139587 197895 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592563 197895 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139950 197898 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592581 197898 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139766 197936 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592806 197936 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272869 193801 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 193801 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45140556 198577 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597150 198577 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232830 197484 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589520 197484 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142221 197450 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589283 197450 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128980 81893 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
CHEMBL2172143 81893 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
44129445 81931 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172266 81931 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45485860 195775 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 195775 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 195551 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 195551 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45487850 195311 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 195311 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45268630 194404 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560748 194404 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139401 198990 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599825 198990 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232937 197586 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590259 197586 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232924 199164 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601270 199164 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233589 198580 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597158 198580 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11649278 14731 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208091 14731 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496022 14731 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268630 194404 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 194404 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
121990 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1710 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1763 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
CHEMBL435402 75 12 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
45487837 197321 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 197321 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
45270288 193592 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 193592 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 193592 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551217 193592 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272881 193182 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 193182 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129449 81913 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172163 81913 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272881 193182 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539983 193182 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140156 198932 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599400 198932 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272055 193214 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 193214 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272055 193214 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540737 193214 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485895 195579 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568498 195579 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270296 193649 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 193649 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11955421 197353 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 197353 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45270296 193649 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551620 193649 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273812 194073 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL557535 194073 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271082 193798 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552921 193798 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233355 198855 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598998 198855 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271145 193250 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 193250 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273812 194073 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 194073 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487800 197292 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 197292 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272074 193663 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551750 193663 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233323 199948 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL605964 199948 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
6451084 54662 44 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL1615434 54662 44 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45487843 195507 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 195507 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487841 195118 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 195118 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487809 195267 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 195267 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44125995 81940 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172278 81940 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45267776 194549 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561692 194549 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233322 198961 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599606 198961 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
25124828 14747 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124828 14747 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208131 14747 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208131 14747 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499580 14747 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL499580 14747 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485891 195305 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566753 195305 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45487844 197354 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 197354 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270314 193465 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 193465 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45140746 200015 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL606408 200015 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11955422 195196 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 195196 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
44610760 195624 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 195624 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45141131 197482 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589518 197482 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140929 199242 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601704 199242 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141131 197482 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589518 197482 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232897 197527 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589889 197527 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232881 197538 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589971 197538 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485892 195349 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 195349 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233232 196897 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578482 196897 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485937 195561 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 195561 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139588 197935 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592802 197935 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485947 195859 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 195859 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232891 199238 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601697 199238 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140166 197665 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590748 197665 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485880 195886 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570423 195886 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141987 197448 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589281 197448 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140364 197896 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592570 197896 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140159 197945 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592880 197945 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139406 199060 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600371 199060 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232907 197550 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590007 197550 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139958 197664 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590747 197664 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233235 197841 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592166 197841 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485890 195797 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 195797 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140935 197844 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592195 197844 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232898 199270 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601904 199270 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233326 196882 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578271 196882 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233223 197838 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592163 197838 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232912 199276 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601910 199276 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45272054 193213 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 193213 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
44128981 81894 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172144 81894 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
44129448 81934 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172269 81934 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11955422 195196 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 195196 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
45485865 195678 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569127 195678 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829780 194781 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 194781 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128900 81882 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172131 81882 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44128468 81907 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172157 81907 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
24829780 194781 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563183 194781 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233175 198523 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596769 198523 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140157 198786 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598588 198786 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271100 194989 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 194989 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 194989 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564552 194989 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233239 197869 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592408 197869 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139948 198751 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
CHEMBL598375 198751 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
1149185 195506 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568126 195506 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45487842 197296 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 197296 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487813 195397 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 195397 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140750 197816 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591945 197816 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140743 198754 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598386 198754 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140744 198788 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL598594 198788 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45272842 193941 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 193941 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129525 81946 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172284 81946 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487800 197292 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 197292 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140154 198896 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
CHEMBL599197 198896 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
45487844 197354 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 197354 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270322 193104 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 193104 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45139947 198750 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
CHEMBL598374 198750 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
45269483 193115 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 193115 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66855932 81905 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172155 81905 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45270266 193392 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549594 193392 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233354 198986 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599816 198986 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
45267750 194243 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 194243 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267750 194243 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559340 194243 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140158 199949 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605968 199949 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485939 195464 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 195464 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 195551 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 195551 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44129136 81879 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172128 81879 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855902 81900 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
CHEMBL2172150 81900 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
45141129 197651 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590673 197651 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141584 197950 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592885 197950 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232934 197564 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590114 197564 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44443938 93728 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249584 93728 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9850430 93758 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249789 93758 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9846875 93895 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 93895 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 93895 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
18717762 93936 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250847 93936 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45141985 196975 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579334 196975 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485885 195534 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568257 195534 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232914 199301 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602109 199301 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485941 195336 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 195336 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142220 197401 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL588492 197401 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142452 197953 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592888 197953 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139589 199058 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600369 199058 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142451 199085 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600576 199085 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140367 199033 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600056 199033 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142453 197449 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589282 197449 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141580 197598 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590328 197598 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140749 197807 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591839 197807 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232946 197588 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590261 197588 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232926 199165 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601271 199165 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485862 195792 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 195792 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270274 194075 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL557553 194075 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
66854841 81896 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172146 81896 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
46233231 197840 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592165 197840 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141344 198667 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597772 198667 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485905 195834 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 195834 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233236 196954 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579094 196954 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139773 197368 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL586227 197368 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140368 199034 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600057 199034 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485919 195105 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 195105 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139403 197889 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592531 197889 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232913 199300 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602108 199300 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232919 199305 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602112 199305 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
11585281 14746 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208129 14746 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499428 14746 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123181 14736 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1208106 14736 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL496820 14736 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
66856658 81904 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
CHEMBL2172154 81904 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
44631970 193170 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 193170 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 193170 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 193170 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
71449929 81930 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172265 81930 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 195160 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 195160 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856790 81902 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
CHEMBL2172152 81902 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
45140927 197490 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589550 197490 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233133 197767 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591510 197767 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25123181 14736 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208106 14736 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496820 14736 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485851 195746 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 195746 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233132 199465 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603333 199465 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66854424 81911 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172161 81911 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855084 81912 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172162 81912 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129447 81933 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172268 81933 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66920261 81944 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172281 81944 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 195160 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 195160 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45141133 196886 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578324 196886 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233224 198963 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599634 198963 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232892 197522 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589828 197522 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139957 199440 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603149 199440 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233225 196780 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577433 196780 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232906 197506 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589697 197506 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232918 197552 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590009 197552 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44631974 199272 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 199272 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9846875 93895 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 93895 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 93895 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
66854759 81884 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172133 81884 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141771 197660 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590743 197660 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141984 197825 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592021 197825 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232888 197529 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589897 197529 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232901 197548 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590005 197548 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 199273 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 199273 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485909 195826 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 195826 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139586 197925 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592737 197925 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139402 198966 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599637 198966 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45270314 193465 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL550206 193465 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
66854409 81909 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172159 81909 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233131 198861 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599020 198861 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25127813 14729 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208083 14729 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL495605 14729 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45142446 198666 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597765 198666 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25124162 59928 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1671994 59928 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1741096 59928 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
25128136 14704 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207855 14704 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL446904 14704 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45273789 194223 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 194223 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45273789 194223 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL559126 194223 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45141130 197452 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589290 197452 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44129446 81932 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172267 81932 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
9969173 196789 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL577508 196789 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
25123183 14752 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
25123183 14752 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL1208235 14752 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL1208235 14752 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL509572 14752 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL509572 14752 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
25124484 14566 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124484 14566 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206415 14566 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206415 14566 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271672 14566 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL271672 14566 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45269454 194434 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 194434 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142449 194646 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 194646 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487821 195432 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 195432 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45269454 194434 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561007 194434 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142449 194646 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562344 194646 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
136677322 3232 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
1739 3232 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
656725 3232 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
CHEMBL1160031 3232 22 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
45270321 193837 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 193837 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
45139400 198547 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596939 198547 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 193171 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 193171 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 195037 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 195037 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 195037 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564981 195037 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141585 197682 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590939 197682 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485942 195840 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 195840 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232948 199206 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601488 199206 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855824 81937 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172272 81937 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46232928 199167 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601273 199167 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485940 195075 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565300 195075 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485916 195216 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 195216 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139590 199086 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600577 199086 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485913 196103 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571929 196103 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139591 198723 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598160 198723 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232880 197537 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589961 197537 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141583 196919 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578714 196919 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142450 199083 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600574 199083 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
5906 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
66855377 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
CHEMBL2172140 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
5906 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
66855377 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
CHEMBL2172140 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
44129369 81901 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
CHEMBL2172151 81901 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
45140933 197756 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591427 197756 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139952 198550 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596961 198550 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139956 199439 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603148 199439 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232889 197546 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590003 197546 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485883 195795 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569913 195795 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123505 14738 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL1208113 14738 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL498038 14738 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
44129371 81897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172147 81897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
45485852 195738 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 195738 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270267 193415 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549797 193415 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233357 199885 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605565 199885 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
13782419 14567 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206416 14567 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271673 14567 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
11670815 195514 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 195514 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
45273782 193826 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 193826 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273782 193826 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL553654 193826 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487842 197296 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 197296 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487790 197294 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 197294 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45139946 198517 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596733 198517 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
20638786 154411 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL401158 154411 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
11950159 195429 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 195429 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233176 199676 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604497 199676 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232885 197545 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590002 197545 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485948 195877 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570384 195877 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140753 197671 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590771 197671 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232905 197499 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589616 197499 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485945 195392 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 195392 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485951 195864 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570271 195864 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 196057 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 196057 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140752 197679 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590856 197679 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140362 197750 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591367 197750 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232909 197535 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589927 197535 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233227 197839 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592164 197839 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232908 199274 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601908 199274 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140163 197642 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590602 197642 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140555 197690 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590989 197690 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139954 198929 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599397 198929 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232910 199275 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601909 199275 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45269484 193982 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 193982 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
66857005 81903 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
CHEMBL2172153 81903 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
45270295 193093 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 193093 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128983 81891 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172141 81891 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45487838 195623 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 195623 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
46233095 197727 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL591212 197727 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
46233134 197773 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
CHEMBL591536 197773 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
16681707 746 4 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
1767 746 4 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
CHEMBL2172275 746 4 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
46233451 198696 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597980 198696 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25128135 14735 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208102 14735 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496620 14735 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45140161 197791 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591691 197791 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
168293759 191559 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5203993 191559 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
46233174 198995 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599843 198995 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141773 199435 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603144 199435 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233226 196799 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577653 196799 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233238 197868 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592407 197868 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485921 195333 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 195333 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485894 195767 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 195767 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141345 196782 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577454 196782 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140363 197910 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592671 197910 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141578 197589 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590262 197589 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272861 193800 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552971 193800 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141774 197951 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592886 197951 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232929 197584 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590257 197584 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45267728 194522 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 194522 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268641 193160 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 193160 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142447 198729 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598177 198729 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139764 198789 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL598612 198789 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
45269473 194656 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 194656 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
71462475 81936 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172271 81936 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45267722 194416 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 194416 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 194416 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560882 194416 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
22916 14541 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
22916 14541 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206272 14541 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206272 14541 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL256057 14541 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL256057 14541 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45270300 193716 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 193716 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273811 194812 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 194812 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270300 193716 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552022 193716 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
1756 459 8 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
5310954 459 8 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
CHEMBL336292 459 8 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
60606 61216 68 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
CHEMBL1771 61216 68 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
1765 3745 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 3745 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 3745 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 3745 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 3745 94 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1765 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
4184 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
9871419 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
CHEMBL398435 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
DB08816 3745 94 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
1712 285 64 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
6022 285 64 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
CHEMBL14830 285 64 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
44126037 1088 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
5905 1088 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
CHEMBL2172277 1088 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
44583582 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
5904 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
59448166 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL1207916 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL455536 3143 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
1765 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
4184 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
9871419 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
CHEMBL398435 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
DB08816 3745 94 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
23649325 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
23649325 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
7360 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
7360 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
CHEMBL2419490 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
CHEMBL2419490 536 47 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
5906 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
66855377 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
CHEMBL2172140 1006 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
121990 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1710 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1763 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
CHEMBL435402 75 12 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
10000627 2955 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
11136 2955 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
1773 2955 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
56947084 2955 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
10066813 940 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474
1772 940 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474